Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)-Reference-Cited by-同舟云学术

Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)

Published:2013 Issue:3 Volume:37 Page:212-222
ISSN:1421-9670
Container-title:American Journal of Nephrology
language:en
Short-container-title:Am J Nephrol

Author:

de Zeeuw Dick,Akizawa Tadao,Agarwal Rajiv,Audhya Paul,Bakris George L.,Chin Melanie,Krauth Melissa,Lambers Heerspink Hiddo J.,Meyer Colin J.,McMurray John J.,Parving Hans-Henrik,Pergola Pablo E.,Remuzzi Giuseppe,Toto Robert D.,Vaziri Nosratola D.,Wanner Christoph,Warnock David G.,Wittes Janet,Chertow Glenn M.

Publisher

S. Karger AG

Subject

Nephrology

Reference34 articles.

1. The Kidney in Type 2 Diabetes Therapy

2. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

3. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

4. Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Throughput Screening in Drug Discovery: Problems and Solutions;Moscow University Chemistry Bulletin;2024-04

2. Rodent models of AKI and AKI-CKD transition: an update in 2024;American Journal of Physiology-Renal Physiology;2024-04-01

3. HIGH THROUGHPUT SCREENING IN DRUG DISCOVERY: PROBLEMS AND SOLUTIONS;Lomonosov chemistry journal;2024-02-26

4. Antioxidants for adults with chronic kidney disease;Cochrane Database of Systematic Reviews;2023-11-02

5. NRF2 Deficiency Attenuates Diabetic Kidney Disease in Db/Db Mice via Down-Regulation of Angiotensinogen, SGLT2, CD36, and FABP4 Expression and Lipid Accumulation in Renal Proximal Tubular Cells;Antioxidants;2023-09-04